Company intelligence / Profile preview

Vizlitics

United States

Ownership: Private
Development stage: Other

Overview

Vizlitics (d/b/a Cancer Insights) offers three commercial AI-based oncology workflow solutions: New Consult Workflow, Tumor Board Management, and Oncology Data Insights. These products streamline patient onboarding, tumor board management, and oncology data extraction via advanced NLP and reinforcement learning, enabling improved clinical and operational outcomes for oncology providers. Their platform is clinically validated and integrated with EMR systems, processing records from the majority of US health systems.

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Vizlitics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vizlitics.

Explore the full profile